On the public citation graph
Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
0 signed · 393 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1006/mpat.1997.0188openalex-snapshot
V antigen ofYersinia pestisinhibits neutrophil chemotaxis
inferredcites →https://doi.org/10.1016/0022-1759(90)90029-uopenalex-snapshot
Removal of endotoxin from protein solutions by phase separation using triton X-114
inferredcites →https://doi.org/10.1016/0378-1119(91)90016-5openalex-snapshot
Escherichia-Pseudomonas shuttle vectors derived from pUC18/19
inferredcites →https://doi.org/10.1016/s0021-9258(17)34078-4openalex-snapshot
Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388.
inferredcites →https://doi.org/10.1016/s0966-842x(97)01029-9openalex-snapshot
Type III secretion systems: machines to deliver bacterial proteins into eukaryotic cells?
inferredcites →https://doi.org/10.1046/j.1365-2958.1996.01554.xopenalex-snapshot
Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway
inferredcites →https://doi.org/10.1046/j.1365-2958.1997.2731623.xopenalex-snapshot
The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells
inferredcites →https://doi.org/10.1046/j.1365-2958.1997.4891851.xopenalex-snapshot
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
inferredcites →https://doi.org/10.1046/j.1365-2958.1997.5411905.xopenalex-snapshot
Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III‐dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments
inferredcites →https://doi.org/10.1046/j.1365-2958.1997.6251991.xopenalex-snapshot
The exoenzyme S regulon of Pseudomonas aeruginosa
inferredcites →https://doi.org/10.1046/j.1365-2958.1998.00727.xopenalex-snapshot
PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence
inferredcites →https://doi.org/10.1046/j.1365-2958.1998.00994.xopenalex-snapshot
Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis
inferredcites →https://doi.org/10.1073/pnas.95.23.13899openalex-snapshot
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
inferredcites →https://doi.org/10.1074/jbc.273.13.7332openalex-snapshot
Pseudomonas aeruginosa Exoenzyme S ADP-ribosylates Ras at Multiple Sites
inferredcites →https://doi.org/10.1111/j.1365-2958.1992.tb01558.xopenalex-snapshot
Alielic exchange in Pseudomonas aeruginosa using novel ColE1‐type vectors and a family of cassettes containing a portable oriT and the counter‐selectable Bacillus subtilis sacB marker
inferredcites →https://doi.org/10.1128/.67.4.2040-2044.1999openalex-snapshot
Biological Effects of Pseudomonas aeruginosa Type III-Secreted Proteins on CHO Cells
inferredcites →https://doi.org/10.1128/iai.57.3.996-998.1989openalex-snapshot
Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin
inferredcites →https://doi.org/10.1128/iai.59.11.4259-4262.1991openalex-snapshot
ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S
inferredcites →https://doi.org/10.1128/iai.62.10.4192-4201.1994openalex-snapshot
Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide
inferredcites →https://doi.org/10.1128/iai.62.2.554-563.1994openalex-snapshot
Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus
inferredcites →https://doi.org/10.1128/iai.63.4.1541-1551.1995openalex-snapshot
Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing
inferredcites →https://doi.org/10.1128/iai.63.8.2854-2858.1995openalex-snapshot
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague
inferredcites →https://doi.org/10.1128/iai.63.8.3021-3029.1995openalex-snapshot
Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization
inferredcites →https://doi.org/10.1128/iai.63.8.3117-3124.1995openalex-snapshot
Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells
inferredcites →https://doi.org/10.1128/iai.64.11.4580-4585.1996openalex-snapshot
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis
inferredcites →https://doi.org/10.1128/iai.65.2.579-586.1997openalex-snapshot
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S
inferredcites →https://doi.org/10.1128/iai.65.4.1196-1203.1997openalex-snapshot
Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10
inferredcites →https://doi.org/10.1128/iai.65.8.3304-3309.1997openalex-snapshot
Ecto-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exoenzyme S
inferredcites →https://doi.org/10.1128/iai.66.7.3242-3249.1998openalex-snapshot
In Vitro Cellular Toxicity Predicts Pseudomonas aeruginosa Virulence in Lung Infections
inferredcites →https://doi.org/10.1128/iai.67.2.914-920.1999openalex-snapshot
Regulation of ExoS Production and Secretion by Pseudomonas aeruginosa in Response to Tissue Culture Conditions
inferredcites →https://doi.org/10.1128/jb.177.5.1169-1178.1995openalex-snapshot
Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene
inferredcites →https://doi.org/10.1128/jb.177.9.2530-2542.1995openalex-snapshot
Differential effects of deletions in lcrV on secretion of V antigen, regulation of the low-Ca2+ response, and virulence of Yersinia pestis
inferredcites →https://doi.org/10.1128/jb.178.5.1412-1419.1996openalex-snapshot
Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa
inferredcites →https://doi.org/10.1128/jb.179.22.7165-7168.1997openalex-snapshot
Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon
inferredcites →https://doi.org/10.1128/jb.180.13.3410-3420.1998openalex-snapshot
The V Antigen of Yersinia pestis Regulates Yop Vectorial Targeting as Well as Yop Secretion through Effects on YopB and LcrG
inferredcites →https://doi.org/10.1128/jb.180.21.5495-5504.1998openalex-snapshot
TheYersiniaDeadly Kiss
inferredcites →https://doi.org/10.1128/jb.180.5.1207-1214.1998openalex-snapshot
The Yersinia Yop Virulon: LcrV Is Required for Extrusion of the Translocators YopB and YopD
inferredcites →https://doi.org/10.1128/mmbr.62.2.379-433.1998openalex-snapshot
Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants
inferredcites →https://doi.org/10.1152/ajplung.1994.267.5.l551openalex-snapshot
Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury
inferredcites →https://doi.org/10.4049/jimmunol.159.6.2858openalex-snapshot
IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.5281/zenodo.1303954openalex-extracted
Immunoprophylaxis Of Pseudomonosis: Achievements And Perspectives
inferred← citeshttps://doi.org/10.1001/jama.293.5.581openalex-snapshot
Longitudinal Development of Mucoid Pseudomonas aeruginosa Infection and Lung Disease Progression in Children With Cystic Fibrosis
inferred← citeshttps://doi.org/10.1001/jamaophthalmol.2013.1610openalex-snapshot
Corticosteroids for Bacterial Keratitis
inferred← citeshttps://doi.org/10.1002/adfm.202108917openalex-snapshot
Whole‐Cell‐Mimicking Carrier‐Free Nanovaccines Amplify Immune Responses Against Cancer and Bacterial Infection
inferred← citeshttps://doi.org/10.1002/ijch.201300025openalex-snapshot
Discovery and Mechanism of Type III Secretion System Inhibitors
inferred← citeshttps://doi.org/10.1002/ppul.20194openalex-snapshot
Detection ofPseudomonas aeruginosa type III antibodies in children with tracheostomies
inferred← citeshttps://doi.org/10.1002/ppul.21022openalex-snapshot
Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis
inferred← citeshttps://doi.org/10.1002/ppul.22890openalex-snapshot
Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection
inferred← citeshttps://doi.org/10.1006/mpat.2002.0498openalex-snapshot
Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis
inferred← citeshttps://doi.org/10.1006/mpat.2002.0534openalex-snapshot
Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1007/0-387-30746-x_14openalex-snapshot
Yersinia pestis and Bubonic Plague
inferred← citeshttps://doi.org/10.1007/3-540-27511-8_8openalex-snapshot
The Type III Cytotoxins of Yersinia and Pseudomonas aeruginosa That Modulate the Actin Cytoskeleton
inferred← citeshttps://doi.org/10.1007/978-1-4419-9086-0_25openalex-snapshot
Protein Secretion Mechanisms in Pseudomonas
inferred← citeshttps://doi.org/10.1007/978-1-4615-0053-7_17openalex-snapshot
Vaccines for Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1007/978-1-4615-0433-7_12openalex-snapshot
New Perspectives on Prevention and Management of Pseudomonas Aeruginosa Infections
inferred← citeshttps://doi.org/10.1007/978-1-4615-0433-7_13openalex-snapshot
Molecular Pathogenesis of Acute Pseudomonas Aeruginosa Infections
inferred← citeshttps://doi.org/10.1007/978-1-4615-1427-5_10openalex-snapshot
Mechanisms of Lung Epithelial Cell Injury by Pseudomonas Aeruginosa
inferred← citeshttps://doi.org/10.1007/978-1-4939-0473-0_14openalex-snapshot
In vitro Assays to Monitor the Activity of Pseudomonas aeruginosa Type III Secreted Proteins
inferred← citeshttps://doi.org/10.1007/978-2-8178-0389-0_8openalex-snapshot
Les thérapeutiques infectieuses non antibiotiques
inferred← citeshttps://doi.org/10.1007/978-3-031-08491-1_9openalex-snapshot
Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System
inferred← citeshttps://doi.org/10.1007/978-3-0348-0977-1_8openalex-snapshot
Anti-Inflammatory Therapies for Cystic Fibrosis
inferred← citeshttps://doi.org/10.1007/b100191openalex-snapshot
ExoU: A cytotoxin delivered by the type III secretion system of Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1007/s00134-012-2699-5openalex-snapshot
Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains
inferred← citeshttps://doi.org/10.1007/s00210-025-04941-yopenalex-snapshot
Bibliometric analysis of Pseudomonas aeruginosa vaccine development highlighting research status, evolution, and future opportunities
inferred← citeshttps://doi.org/10.1007/s004300050118openalex-snapshot
Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype O8 by macrophages
inferred← citeshttps://doi.org/10.1007/s10096-011-1509-2openalex-snapshot
PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice
inferred← citeshttps://doi.org/10.1007/s10930-012-9416-7openalex-snapshot
Characterization of Molten Globule PopB in Absence and Presence of Its Chaperone PcrH
inferred← citeshttps://doi.org/10.1007/s13546-012-0472-yopenalex-snapshot
Les thérapeutiques anti-infectieuses non antibiotiques
inferred← citeshttps://doi.org/10.1007/s13546-013-0679-6openalex-snapshot
Nouveautés et perspectives thérapeutiques des pneumonies acquises sous ventilation mécanique à Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/b978-0-12-397169-2.00041-xopenalex-snapshot
Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/b978-0-12-800188-2.00005-7openalex-snapshot
Pseudomonas aeruginosa toxins
inferred← citeshttps://doi.org/10.1016/b978-0-12-818619-0.00064-2openalex-snapshot
Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/b978-0-12-819541-3.00006-2openalex-snapshot
Superbugs, silver bullets, and new battlefields
inferred← citeshttps://doi.org/10.1016/b978-0-443-06839-3.00219-8openalex-snapshot
Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/b978-012088445-2/50019-6openalex-snapshot
Pseudomonas aeruginosa toxins
inferred← citeshttps://doi.org/10.1016/b978-2-294-08855-1.50107-8openalex-snapshot
10.1016/b978-2-294-08855-1.50107-8
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2016.05.003openalex-snapshot
In Vitro Analysis of Pseudomonas aeruginosa Virulence Using Conditions That Mimic the Environment at Specific Infection Sites
inferred← citeshttps://doi.org/10.1016/j.ajps.2026.101162openalex-snapshot
Bispecific antibody vesicles: A multifunctional bioactive drug delivery platform for the treatment of Pseudomonas aeruginosa infection
inferred← citeshttps://doi.org/10.1016/j.atc.2004.05.002openalex-snapshot
A therapeutic strategy against the shared virulence mechanism utilized by both Yersinia pestis and Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2004.03.011openalex-snapshot
Type III protein secretion mechanism in mammalian and plant pathogens
inferred← citeshttps://doi.org/10.1016/j.burns.2004.09.002openalex-snapshot
Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge
inferred← citeshttps://doi.org/10.1016/j.ccm.2004.10.017openalex-snapshot
Etiology of Ventilator-Associated Pneumonia
inferred← citeshttps://doi.org/10.1016/j.cell.2023.10.002openalex-snapshot
Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/j.chom.2014.01.003openalex-snapshot
A Type III Secretion Negative Clinical Strain of Pseudomonas aeruginosa Employs a Two-Partner Secreted Exolysin to Induce Hemorrhagic Pneumonia
inferred← citeshttps://doi.org/10.1016/j.cmi.2018.08.004openalex-snapshot
Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
inferred← citeshttps://doi.org/10.1016/j.femsle.2005.06.044openalex-snapshot
Actin cytoskeleton disruption by ExoY and its effects onPseudomonas aeruginosainvasion
inferred← citeshttps://doi.org/10.1016/j.femsre.2005.01.001openalex-snapshot
Bioinformatics, genomics and evolution of non-flagellar type-III secretion systems: a Darwinian perpective
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2020.05.057openalex-snapshot
Oligomerization of IC43 resulted in improved immunogenicity and protective efficacy against Pseudomonas aeruginosa lung infection
inferred← citeshttps://doi.org/10.1016/j.ijid.2019.08.008openalex-snapshot
Anti-PcrV titers in non-cystic fibrosis patients with Pseudomonas aeruginosa respiratory tract infection
inferred← citeshttps://doi.org/10.1016/j.ijmm.2007.02.004openalex-snapshot
A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates
inferred← citeshttps://doi.org/10.1016/j.ijmm.2010.08.005openalex-snapshot
Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
inferred← citeshttps://doi.org/10.1016/j.ijmm.2010.08.010openalex-snapshot
Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
inferred← citeshttps://doi.org/10.1016/j.jcf.2017.12.006openalex-snapshot
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.113860openalex-snapshot
Highly pure mRNA vaccine provides robust immunization against P. aeruginosa by minimizing type I interferon responses
inferred← citeshttps://doi.org/10.1016/j.jiac.2015.10.005openalex-snapshot
Keratinocyte growth factor-2 inhibits bacterial infection with Pseudomonas aeruginosa pneumonia in a mouse model
inferred← citeshttps://doi.org/10.1016/j.jiac.2016.01.006openalex-snapshot
Protective effects of intravenous immunoglobulin and antimicrobial agents on acute pneumonia in leukopenic mice
inferred← citeshttps://doi.org/10.1016/j.lfs.2025.123930openalex-snapshot
CpG-mediated TLR9 signaling pathway enhances the efficacy of the OprF/PcrV DNA vaccine with cGAS-STING-activating properties
inferred← citeshttps://doi.org/10.1016/j.medmal.2005.10.007openalex-snapshot
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
inferred← citeshttps://doi.org/10.1016/j.mib.2008.12.007openalex-snapshot
Role of Pseudomonas aeruginosa type III effectors in disease
inferred← citeshttps://doi.org/10.1016/j.micpath.2004.10.005openalex-snapshot
Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN
inferred← citeshttps://doi.org/10.1016/j.micpath.2006.01.003openalex-snapshot
Deletion of the genes encoding the type III secretion system and cytotoxic enterotoxin alters host responses to Aeromonas hydrophila infection
inferred← citeshttps://doi.org/10.1016/j.micpath.2006.10.004openalex-snapshot
The influence of human respiratory epithelia on Pseudomonas aeruginosa gene expression
inferred← citeshttps://doi.org/10.1016/j.micpath.2010.02.008openalex-snapshot
Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV – Implications for anti-PcrV immunotherapy
inferred← citeshttps://doi.org/10.1016/j.micpath.2021.104907openalex-snapshot
Type 3 secretion system as an anti-Pseudomonal target
inferred← citeshttps://doi.org/10.1016/j.molimm.2019.10.005openalex-snapshot
Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2018.05.003openalex-snapshot
Therapeutic antibodies: A new era in the treatment of respiratory diseases?
inferred← citeshttps://doi.org/10.1016/j.plrev.2021.05.007openalex-snapshot
An elegant nano-injection machinery for sabotaging the host: Role of Type III secretion system in virulence of different human and animal pathogenic bacteria
inferred← citeshttps://doi.org/10.1016/j.resinv.2021.12.002openalex-snapshot
Serological immune response against major secretory proteins expressed by Pseudomonas aeruginosa upon intratracheal infection in mice
inferred← citeshttps://doi.org/10.1016/j.resp.2014.01.001openalex-snapshot
PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury
inferred← citeshttps://doi.org/10.1016/j.tim.2005.05.011openalex-snapshot
Modulation of lung epithelial functions by Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/j.tips.2016.05.011openalex-snapshot
Targeting the Type Three Secretion System in Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/j.vaccine.2003.11.028openalex-snapshot
Pseudomonas immunotherapy: a historical overview
inferred← citeshttps://doi.org/10.1016/j.vaccine.2006.05.077openalex-snapshot
Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/j.vaccine.2007.12.007openalex-snapshot
Vaccines and immunotherapy against Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.10.010openalex-snapshot
PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia
inferred← citeshttps://doi.org/10.1016/j.ygeno.2017.05.001openalex-snapshot
Prediction of vaccine candidates against Pseudomonas aeruginosa: An integrated genomics and proteomics approach
inferred← citeshttps://doi.org/10.1016/s0167-4889(04)00087-4openalex-snapshot
Type III protein secretion mechanism in mammalian and plant pathogens
inferred← citeshttps://doi.org/10.1016/s0264-410x(00)00393-5openalex-snapshot
Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains
inferred← citeshttps://doi.org/10.1016/s0399-077x(02)00010-0openalex-snapshot
Régulation transcriptionnelle du système de sécrétion de type III de Pseudomonas aeruginosa : conséquences de mutations de gènes de la pyruvate déhydrogénase
inferred← citeshttps://doi.org/10.1016/s0928-8244(03)00176-7openalex-snapshot
Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat
inferred← citeshttps://doi.org/10.1016/s0966-842x(99)01671-6openalex-snapshot
‘Pseudomonas ’99, The Seventh International Congress on Pseudomonas: Biotechnology and Pathogenesis’, organized by the American Society for Microbiology, was held in Maui, HI, USA, 1–5 September 1999.
inferred← citeshttps://doi.org/10.1016/s1286-4579(00)01259-4openalex-snapshot
Establishment of infection: lessons from a versatile opportunist
inferred← citeshttps://doi.org/10.1017/cbo9780511546266.008openalex-snapshot
Type III secretion and resistance to phagocytosis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01698openalex-snapshot
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
inferred← citeshttps://doi.org/10.1021/acscentsci.9b00452openalex-snapshot
Tanshinones: First-in-Class Inhibitors of the Biogenesis of the Type 3 Secretion System Needle of Pseudomonas aeruginosa for Antibiotic Therapy
inferred← citeshttps://doi.org/10.1021/acsnano.6c04456openalex-snapshot
Protective-Antigen Scaffold Nanoparticle Vaccine Overcomes Carrier-Induced Suppression and Immunosenescence to Protect against Pseudomonas aeruginosa Pneumonia
inferred← citeshttps://doi.org/10.1021/bi100432eopenalex-snapshot
Analysis of the Crystal Structure of the ExsC·ExsE Complex Reveals Distinctive Binding Interactions of the Pseudomonas aeruginosa Type III Secretion Chaperone ExsC with ExsE and ExsD
inferred← citeshttps://doi.org/10.1021/bi200905xopenalex-snapshot
Efficient Isolation of Pseudomonas aeruginosa Type III Secretion Translocators and Assembly of Heteromeric Transmembrane Pores in Model Membranes
inferred← citeshttps://doi.org/10.1021/np500433zopenalex-snapshot
Solving the Supply of Resveratrol Tetramers from Papua New Guinean Rainforest Anisoptera Species That Inhibit Bacterial Type III Secretion Systems
inferred← citeshttps://doi.org/10.1023/a:1007544804864openalex-snapshot
Novel Lipid-Based Hollow-Porous Microparticles as a Platform for Immunoglobulin Delivery to the Respiratory Tract
inferred← citeshttps://doi.org/10.1038/7372openalex-snapshot
For Pseudomonas aeruginosa, stealth is no longer enough
inferred← citeshttps://doi.org/10.1038/ja.2017.64openalex-snapshot
The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo
inferred← citeshttps://doi.org/10.1038/nrmicro2199openalex-snapshot
The type III secretion system of Pseudomonas aeruginosa: infection by injection
inferred← citeshttps://doi.org/10.1038/s41467-026-71040-8openalex-snapshot
Fc-free single-chain antibody mRNA therapy for airway infection of multidrug-resistant Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1038/s41541-023-00618-wopenalex-snapshot
A protein subunit vaccine elicits a balanced immune response that protects against Pseudomonas pulmonary infection
inferred← citeshttps://doi.org/10.1038/s41598-017-04029-5openalex-snapshot
Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
inferred← citeshttps://doi.org/10.1038/s41598-021-86491-wopenalex-snapshot
Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
inferred← citeshttps://doi.org/10.1038/s41598-022-05157-3openalex-snapshot
Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections
inferred← citeshttps://doi.org/10.1046/j.1365-2958.2001.02368.xopenalex-snapshot
Pore‐forming activity of type III system‐secreted proteins leads to oncosis of Pseudomonas aeruginosa ‐infected macrophages
inferred← citeshttps://doi.org/10.1046/j.1365-2958.2002.03228.xopenalex-snapshot
ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regulon
inferred← citeshttps://doi.org/10.1046/j.1462-5822.2001.00108.xopenalex-snapshot
Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction
inferred← citeshttps://doi.org/10.1073/pnas.0503005102openalex-snapshot
ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1073/pnas.0504405102openalex-snapshot
A secreted regulatory protein couples transcription to the secretory activity of the Pseudomonas aeruginosa type III secretion system
inferred← citeshttps://doi.org/10.1073/pnas.2209383119openalex-snapshot
Catheter-associated urinary tract infection by Pseudomonas aeruginosa progresses through acute and chronic phases of infection
inferred← citeshttps://doi.org/10.1074/jbc.m115.684241openalex-snapshot
High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement
inferred← citeshttps://doi.org/10.1074/jbc.m203632200openalex-snapshot
Interactions of the Type III Secretion Pathway Proteins LcrV and LcrG from Yersinia pestis Are Mediated by Coiled-Coil Domains
inferred← citeshttps://doi.org/10.1074/jbc.m302472200openalex-snapshot
In Vivo Phospholipase Activity of the Pseudomonas aeruginosa Cytotoxin ExoU and Protection of Mammalian Cells with Phospholipase A2 Inhibitors
inferred← citeshttps://doi.org/10.1080/17460441.2020.1803274openalex-snapshot
Novel therapeutic strategies for treatingPseudomonas aeruginosainfection
inferred← citeshttps://doi.org/10.1080/21645515.2016.1209280openalex-snapshot
The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causingPseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1081/lpr-120014760openalex-snapshot
EFFECTS OF Cl2MDP-ENCAPSULATING LIPOSOMES IN A MURINE MODEL OFPSEUDOMONAS AERUGINOSA-INDUCED SEPSIS
inferred← citeshttps://doi.org/10.1084/jem.20020908openalex-snapshot
Yersinia V–Antigen Exploits Toll-like Receptor 2 and CD14 for Interleukin 10–mediated Immunosuppression
inferred← citeshttps://doi.org/10.1084/jem.20120033openalex-snapshot
Identification of broadly protective human antibodies toPseudomonas aeruginosaexopolysaccharide Psl by phenotypic screening
inferred← citeshttps://doi.org/10.1086/320737openalex-snapshot
Type III Protein Secretion Is Associated with Death in Lower Respiratory and Systemic Pseudomonas aeruginosa Infections
inferred← citeshttps://doi.org/10.1086/338196openalex-snapshot
Infection with Unusual Types ofCryptosporidiumIs Not Restricted to Immunocompromised Patients
inferred← citeshttps://doi.org/10.1086/338197openalex-snapshot
Children with Cystic Fibrosis Produce an Immune Response against Exoenzyme S, a Type III Cytotoxin ofPseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1086/338198openalex-snapshot
The Importance of Assessing Effect Modification When Asserting Racial Differences in Associations between Human Leukocyte Antigen Class II Alleles and Hepatitis C Virus Outcomes
inferred← citeshttps://doi.org/10.1086/338201openalex-snapshot
Association between Efavirenz and Selected Psychiatric and Neurological Conditions
inferred← citeshttps://doi.org/10.1086/341069openalex-snapshot
Generation and Characterization of a Protective Monoclonal Antibody to Pseudomonas aeruginosa PcrV
inferred← citeshttps://doi.org/10.1086/376452openalex-snapshot
Comparative Analysis of Type III Effector Translocation byYersinia pseudotuberculosisExpressing Native LcrV or PcrV fromPseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1086/377000openalex-snapshot
Genotypic and Phenotypic Analysis of Type III Secretion System in a Cohort ofPseudomonas aeruginosaBacteremia Isolates: Evidence for a Possible Association between O Serotypes andexoGenes
inferred← citeshttps://doi.org/10.1086/379372openalex-snapshot
Secretion of the Toxin ExoU Is a Marker for Highly Virulent Pseudomonas aeruginosa Isolates Obtained from Patients with Hospital‐Acquired Pneumonia
inferred← citeshttps://doi.org/10.1086/379898openalex-snapshot
PcrH ofPseudomonas aeruginosaIs Essential for Secretion and Assembly of the Type III Translocon
inferred← citeshttps://doi.org/10.1086/430932openalex-snapshot
Protective Anti‐V Antibodies Inhibit Pseudomonas and Yersinia Translocon Assembly within Host Membranes
inferred← citeshttps://doi.org/10.1089/104303401750270913openalex-snapshot
Cross-Strain Protection against Clinical and Laboratory Strains of Pseudomonas aeruginosa Mediated by Dendritic Cells Genetically Modified to Express CD40 Ligand and Pulsed with Specific Strains of Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1093/burnst/tkae083openalex-snapshot
Understanding the pathophysiology of Pseudomonas aeruginosa colonization as a guide for future treatment for chronic leg ulcers
inferred← citeshttps://doi.org/10.1093/emboj/cdg499openalex-snapshot
Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas
inferred← citeshttps://doi.org/10.1093/femsre/fuaa054openalex-snapshot
Vaccines for multidrug resistant Gram negative bacteria: lessons from the past for guiding future success
inferred← citeshttps://doi.org/10.1093/infdis/jir045openalex-snapshot
Type II Secretion System of Pseudomonas aeruginosa: In Vivo Evidence of a Significant Role in Death Due to Lung Infection
inferred← citeshttps://doi.org/10.1093/infdis/jiv436openalex-snapshot
Pseudomonas aeruginosaBacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide
inferred← citeshttps://doi.org/10.1093/infdis/jiy438openalex-snapshot
Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Antibody MEDI3902, Are Conserved Among Diverse Global Clinical Isolates
inferred← citeshttps://doi.org/10.1093/jac/dki416openalex-snapshot
Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo
inferred← citeshttps://doi.org/10.1093/jac/dkp201openalex-snapshot
Update on the treatment of Pseudomonas aeruginosa pneumonia
inferred← citeshttps://doi.org/10.1093/nar/gkaa377openalex-snapshot
PvrA is a novel regulator that contributes to Pseudomonas aeruginosa pathogenesis by controlling bacterial utilization of long chain fatty acids
inferred← citeshttps://doi.org/10.1097/00003246-200102000-00032openalex-snapshot
Protective effects of low tidal volume ventilation in a rabbit model of Pseudomonas aeruginosa-induced acute lung injury
inferred← citeshttps://doi.org/10.1097/00003246-200203000-00005openalex-snapshot
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1097/00004630-200109000-00004openalex-snapshot
Pseudomonas Vaccination and Immunotherapy
inferred← citeshttps://doi.org/10.1097/01.ccm.0000089928.84326.d2openalex-snapshot
Pneumonia in the intensive care unit
inferred← citeshttps://doi.org/10.1097/01.ccm.0000145588.79063.07openalex-snapshot
Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU*
inferred← citeshttps://doi.org/10.1097/ccm.0000000000001271openalex-snapshot
IV Immunoglobulin for Acute Lung Injury and Bacteremia in Pseudomonas aeruginosa Pneumonia*
inferred← citeshttps://doi.org/10.1097/ccm.0b013e3181833f63openalex-snapshot
Finding the hidden target in Pseudomonas aeruginosa management*
inferred← citeshttps://doi.org/10.1097/ccm.0b013e318183f3f8openalex-snapshot
Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection*
inferred← citeshttps://doi.org/10.1097/ccm.0b013e31819ff137openalex-snapshot
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
inferred← citeshttps://doi.org/10.1097/ccm.0b013e3181de18f0openalex-snapshot
Perivascular fluid cuffs decrease lung compliance by increasing tissue resistance*
inferred← citeshttps://doi.org/10.1097/ccm.0b013e31821e899fopenalex-snapshot
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia*
inferred← citeshttps://doi.org/10.1097/ccm.0b013e31823c8b55openalex-snapshot
Pseudomonas aeruginosa bacteremia
inferred← citeshttps://doi.org/10.1097/ccm.0b013e31825334f6openalex-snapshot
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1097/ccm.0b013e318258e5bbopenalex-snapshot
Ventilator-associated pneumonia caused by Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1097/ccm.0b013e318298a86fopenalex-snapshot
Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa*
inferred← citeshttps://doi.org/10.1097/mcc.0b013e32830f1dd5openalex-snapshot
Novel strategies to combat bacterial virulence
inferred← citeshttps://doi.org/10.1097/mcp.0b013e3283520fecopenalex-snapshot
New therapies for pneumonia
inferred← citeshttps://doi.org/10.1097/qco.0000000000000505openalex-snapshot
Rational approach in the management of Pseudomonas aeruginosa infections
inferred← citeshttps://doi.org/10.1097/shk.0000000000001846openalex-snapshot
Therapeutic Effects of Hyaluronic Acid Against Cytotoxic Extracellular Vesicles Released During Pseudomonas Aeruginosa Pneumonia
inferred← citeshttps://doi.org/10.1098/rstb.2000.0608openalex-snapshot
Type III secretion: a bacterial device for close combat with cells of their eukaryotic host
inferred← citeshttps://doi.org/10.1099/jmm.0.46658-0openalex-snapshot
Immunization with 3-oxododecanoyl-l-homoserine lactone–protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection
inferred← citeshttps://doi.org/10.1099/mic.0.033241-0openalex-snapshot
Role of host cell polarity and leading edge properties in Pseudomonas type III secretion
inferred← citeshttps://doi.org/10.1099/mic.0.2008/019281-0openalex-snapshot
Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis
inferred← citeshttps://doi.org/10.1099/mic.0.26322-0openalex-snapshot
Dissection of homologous translocon operons reveals a distinct role for YopD in type III secretion by Yersinia pseudotuberculosis
inferred← citeshttps://doi.org/10.1099/mic.0.27146-0openalex-snapshot
Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis
inferred← citeshttps://doi.org/10.1099/mic.0.28277-0openalex-snapshot
Factors triggering type III secretion in Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1101/2023.06.09.544431openalex-snapshot
mRNA vaccine induces protective immunity against the type III secretory virulence of Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1111/1348-0421.12147openalex-snapshot
V‐antigen homologs in pathogenic gram‐negative bacteria
inferred← citeshttps://doi.org/10.1111/1348-0421.12353openalex-snapshot
Epidemiological analysis of serum anti‐Pseudomonas aeruginosa PcrV titers in adults
inferred← citeshttps://doi.org/10.1111/1348-0421.12467openalex-snapshot
Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia
inferred← citeshttps://doi.org/10.1111/1348-0421.12658openalex-snapshot
The protective effects of nasal PcrV‐CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia
inferred← citeshttps://doi.org/10.1111/1751-7915.13279openalex-snapshot
Immunological blocking of spermidine‐mediated host–pathogen communication provides effective control against Pseudomonas aeruginosa infection
inferred← citeshttps://doi.org/10.1111/j.1348-0421.2008.00028.xopenalex-snapshot
The Bordetella type III secretion system: its application to vaccine development
inferred← citeshttps://doi.org/10.1111/j.1348-0421.2009.00165.xopenalex-snapshot
Protective effects of affinity‐purified antibody and truncated vaccines against Pseudomonas aeruginosa V‐antigen in neutropenic mice
inferred← citeshttps://doi.org/10.1111/j.1365-2958.2004.04128.xopenalex-snapshot
A novel anti‐anti‐activator mechanism regulates expression of the Pseudomonas aeruginosa type III secretion system
inferred← citeshttps://doi.org/10.1111/j.1365-2958.2005.04552.xopenalex-snapshot
Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis
inferred← citeshttps://doi.org/10.1111/j.1365-2958.2005.04990.xopenalex-snapshot
Metabolic regulation of type III secretion gene expression in Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1111/j.1365-2958.2008.06179.xopenalex-snapshot
Characterization of ExsA and of ExsA‐dependent promoters required for expression of the Pseudomonas aeruginosa type III secretion system
inferred← citeshttps://doi.org/10.1111/j.1365-2958.2008.06237.xopenalex-snapshot
The type III secretion system tip complex and translocon
inferred← citeshttps://doi.org/10.1111/j.1365-2958.2009.07027.xopenalex-snapshot
Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV
inferred← citeshttps://doi.org/10.1111/j.1462-5822.2010.01541.xopenalex-snapshot
Pseudomonas aeruginosa pilin activates the inflammasome
inferred← citeshttps://doi.org/10.1111/j.1469-0691.2005.01241.xopenalex-snapshot
Advances in the management of pneumonia in the intensive care unit: review of current thinking
inferred← citeshttps://doi.org/10.1111/j.1469-0691.2007.01939.xopenalex-snapshot
Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1111/j.1574-695x.2006.00103.xopenalex-snapshot
Antibody responses induced by long-term vaccination with an octovalent conjugatePseudomonas aeruginosavaccine in children with cystic fibrosis
inferred← citeshttps://doi.org/10.1111/j.1574-6976.2010.00257.xopenalex-snapshot
Pertussis: a matter of immune modulation
inferred← citeshttps://doi.org/10.1111/j.1574-6976.2012.00342.xopenalex-snapshot
Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function
inferred← citeshttps://doi.org/10.1111/j.1600-0463.2012.02888.xopenalex-snapshot
Type III apparatus of P seudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients
inferred← citeshttps://doi.org/10.1111/j.1742-4658.2010.07974.xopenalex-snapshot
Membrane targeting and pore formation by the type III secretion system translocon
inferred← citeshttps://doi.org/10.1111/mmi.12185openalex-snapshot
Functional insights into the S higella type III needle tip IpaD in secretion control and cell contact
inferred← citeshttps://doi.org/10.1126/scitranslmed.3009655openalex-snapshot
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1126/scitranslmed.adp1349openalex-snapshot
Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection
inferred← citeshttps://doi.org/10.1128/9781555815851.ch1openalex-snapshot
Type III Secretory Proteins inPseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1128/9781555817329.ch9openalex-snapshot
Protein Secretion andChlamydiaPathogenesis
inferred← citeshttps://doi.org/10.1128/9781555818104.ch15openalex-snapshot
Pseudomonas aeruginosaInfections
inferred← citeshttps://doi.org/10.1128/aac.00694-24openalex-snapshot
Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal Pseudomonas aeruginosa infection via inhibition of toxin translocation by the type III secretion system
inferred← citeshttps://doi.org/10.1128/aac.02242-15openalex-snapshot
Inhibition of Pseudomonas aeruginosa ExsA DNA-Binding Activity by N -Hydroxybenzimidazoles
inferred← citeshttps://doi.org/10.1128/aac.02643-14openalex-snapshot
A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models
showing the first 200 of 353 · page through all 353
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.